BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okuda Y, Ishikura K, Terano C, Harada R, Hamada R, Hataya H, Ogata K, Honda M. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab: An infant with eculizumab-resistant aHUS. Nephrology 2016;21:261-5. [DOI: 10.1111/nep.12582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Terano C, Ishikura K, Hamada R, Yoshida Y, Kubota W, Okuda Y, Shinozuka S, Harada R, Iyoda S, Fujimura Y, Hamasaki Y, Hataya H, Honda M. Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients. Nephrology (Carlton) 2018;23:539-45. [PMID: 28387984 DOI: 10.1111/nep.13054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Vazquez Martul E. [Thrombotic microangiopathy/haemolytic uraemic syndrome. Histopathology update]. Rev Esp Patol 2018;51:170-7. [PMID: 30012310 DOI: 10.1016/j.patol.2017.10.007] [Reference Citation Analysis]